The world’s worst outbreak of Ebola has killed close to 1,100 people in West Africa and the disease could continue spreading for months, increasing pressure on researchers to accelerate the development of therapeutic interventions.
According to new surveillance statistics released on Friday from the Centers for Disease Control and Prevention (CDC), forty-seven states in the U.S. are now reporting widespread influenza activity . The virus, which first appeared in the Southeast, has reached epidemic levels.
Researchers funded by the National Institutes of Health have developed a new silk-based stabilizer that, in the laboratory, kept some vaccines and antibiotics stable up to temperatures of 140 degrees Fahrenheit. This provides a new avenue toward eliminating the need to keep some vaccines and antibiotics refrigerated, which could save billions of dollars every year and increase accessibility to third world populations.